Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Work In Process (2021 - 2026)

Organogenesis Holdings has reported Work In Process over the past 5 years, most recently at $1.3 million for Q4 2025.

  • For Q4 2025, Work In Process rose 37.05% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 37.05%, while the annual FY2025 figure was $1.3 million, 37.05% up from the prior year.
  • Work In Process for Q4 2025 was $1.3 million at Organogenesis Holdings, up from $1.1 million in the prior quarter.
  • Over five years, Work In Process peaked at $1.7 million in Q2 2023 and troughed at $810000.0 in Q4 2023.
  • A 5-year average of $1.1 million and a median of $1.0 million in 2022 define the central range for Work In Process.
  • Biggest five-year swings in Work In Process: skyrocketed 64.94% in 2023 and later tumbled 50.67% in 2024.
  • Year by year, Work In Process stood at $991000.0 in 2021, then grew by 3.13% to $1.0 million in 2022, then decreased by 20.74% to $810000.0 in 2023, then increased by 13.95% to $923000.0 in 2024, then surged by 37.05% to $1.3 million in 2025.
  • Business Quant data shows Work In Process for ORGO at $1.3 million in Q4 2025, $1.1 million in Q3 2025, and $825000.0 in Q2 2025.